1 |
Busulfan, cyclophosphamide, antithymocyte globulin |
Busulfan |
3件: D00248 D00248, D00287 D00287, D07760 D07760 💬 |
- |
- |
019 2件: 19, 20 💬 |
2 |
Busulfan, cyclophosphamide, atg |
Busulfan |
3件: D00248 D00248, D00287 D00287, D07760 D07760 💬 |
- |
- |
019 1件: 19 💬 |
3 |
Busulfan, cyclophosphamide, atg, gcsf |
Busulfan |
3件: D00248 D00248, D00287 D00287, D07760 D07760 💬 |
- |
- |
065 2件: 65, 284 💬 |
4 |
Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen) |
Antithymocyte immunoglobulin (rabbit) |
5件: D00248 D00248, D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
326 1件: 326 💬 |
5 |
Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine. |
Busulfan |
6件: D00184 D00184, D00248 D00248, D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
PPP3CA 6件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2, RRM1 💬 |
Alzheimer disease 37件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Drug metabolism - other enzymes, Glucagon signaling pathway, Glutamatergic synapse, Glutathione metabolism, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Purine metabolism, Pyrimidine metabolism, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 2件: 60, 285 💬 |
6 |
Campath, fludarabine, cyclophosphamide |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 2件: 65, 284 💬 |
7 |
Cyclophosphamid |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
066 1件: 66 💬 |
8 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
9 |
Cyclophosphamide (cy) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
10 |
Cyclophosphamide (cy) (plan 1) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 2件: 60, 285 💬 |
11 |
Cyclophosphamide (cy) (plan 2) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 2件: 60, 285 💬 |
12 |
Cyclophosphamide (cytoxan) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 1件: 65 💬 |
13 |
Cyclophosphamide (drug) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
14 |
Cyclophosphamide + pred |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
283 1件: 283 💬 |
15 |
Cyclophosphamide 100mg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
16 |
Cyclophosphamide 150mg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
17 |
Cyclophosphamide 30 |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 3件: 65, 285, 326 💬 |
18 |
Cyclophosphamide 40 |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 3件: 65, 285, 326 💬 |
19 |
Cyclophosphamide 50mg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
20 |
Cyclophosphamide 50mg oral tablet |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
162 1件: 162 💬 |
21 |
Cyclophosphamide and atg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
22 |
Cyclophosphamide and fludarabine |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
23 |
Cyclophosphamide and steroids |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
222 1件: 222 💬 |
24 |
Cyclophosphamide dose level 1 |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 2件: 65, 284 💬 |
25 |
Cyclophosphamide dose level 2 |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 2件: 65, 284 💬 |
26 |
Cyclophosphamide dose level 3 |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 2件: 65, 284 💬 |
27 |
Cyclophosphamide dose level 4 |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 2件: 65, 284 💬 |
28 |
Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids |
Azathioprine |
6件: D00142 D00142, D00238 D00238, D00287 D00287, D02115 D02115, D03033 D03033, D07760 D07760 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
044 1件: 44 💬 |
29 |
Cyclophosphamide injection 1g |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
050 3件: 50, 51, 52 💬 |
30 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 4件: 13, 60, 96, 256 💬 |
31 |
Cyclophosphamide post transplant |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 1件: 65 💬 |
32 |
Cyclophosphamide(ctx) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
224 1件: 224 💬 |
33 |
Cyclophosphamide, azathioprine,prednisone,methylprednisolone |
Azathioprine |
11件: D00238 D00238, D00287 D00287, D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D03033 D03033, D05000 D05000, D05001 D05001, D05002 D05002, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
042 3件: 42, 43, 45 💬 |
34 |
Cyclophosphamide, bortezomib, and dexamethasone (cybord) |
Bortezomib |
12件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 2件: NR3C1, PSMB5 💬 |
Alzheimer disease 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 1件: 28 💬 |
35 |
Cyclophosphamide, bortezomib, dexamethasone |
Bortezomib |
12件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760 💬 |
NR3C1 2件: NR3C1, PSMB5 💬 |
Alzheimer disease 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 1件: 28 💬 |
36 |
Cyclophosphamide, bortezomib, dexamethasone plus daratumumab |
Bortezomib |
13件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D03150 D03150, D07760 D07760, D10777 D10777 💬 |
CD38 3件: CD38, NR3C1, PSMB5 💬 |
Alzheimer disease 16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia |
028 1件: 28 💬 |
37 |
Cyclophosphamide, fludarabine |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
285 1件: 285 💬 |
38 |
Cyclophosphamide, fludarabine , thymoglobulin |
Antithymocyte immunoglobulin (rabbit) |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
060 1件: 60 💬 |
39 |
Cyclophosphamide, fludarabine, rabbit atg |
Antithymocyte immunoglobulin (rabbit) |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
060 1件: 60 💬 |
40 |
Cyclophosphamide, fludarabine, thymoglobulin |
Antithymocyte immunoglobulin (rabbit) |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
060 1件: 60 💬 |
41 |
Cyclophosphamide,campath ih and tbi |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
42 |
Cyclophosphamide,cyclosporine a |
Cyclophosphamide |
3件: D00184 D00184, D00287 D00287, D07760 D07760 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
060 1件: 60 💬 |
43 |
Cyclophosphamide-prednisone-azathioprine |
Azathioprine |
5件: D00238 D00238, D00287 D00287, D00473 D00473, D03033 D03033, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
049 1件: 49 💬 |
44 |
Cyclophosphamide/glatiramer acetate |
Acetate |
3件: D00287 D00287, D04318 D04318, D07760 D07760 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
45 |
Cyclophosphamidum |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
044 1件: 44 💬 |
46 |
Cyclophosphamidum 500 mg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
044 1件: 44 💬 |
47 |
Fludarabine, cyclophosphamide |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
060 1件: 60 💬 |
48 |
Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide'' |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
49 |
High-dose cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
096 1件: 96 💬 |
50 |
Iv cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
051 1件: 51 💬 |
51 |
Lenalidomide, dexamethasone and cyclophosphamide |
Cyclophosphamide |
12件: D00287 D00287, D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592, D04687 D04687, D07760 D07760 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 1件: 28 💬 |
52 |
Prednisone and cyclophosphamide |
Cyclophosphamide |
3件: D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
53 |
Prednisone plus cyclophosphamide |
Cyclophosphamide |
3件: D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 1件: 66 💬 |
54 |
Prednisone, cyclophosphamide |
Cyclophosphamide |
3件: D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
040 1件: 40 💬 |
55 |
Prednisone, methylprednisolone,cyclophosphamides |
Methylprednisolone |
7件: D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
042 3件: 42, 43, 45 💬 |
56 |
Procedure: cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
065 1件: 65 💬 |
57 |
Rituximab and cyclophosphamide iv |
Cyclophosphamide |
3件: D00287 D00287, D02994 D02994, D07760 D07760 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
035 1件: 35 💬 |
58 |
Thalidomide, cyclophosphamide and prednisone |
Cyclophosphamide |
4件: D00287 D00287, D00473 D00473, D00754 D00754, D07760 D07760 💬 |
NR3C1 2件: NR3C1, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
331 1件: 331 💬 |